First, bioinformatics and immunohistochemical assays supported that LGR6 served as an oncogene-promoting cervical cancer progression and functioned as a prognostic factor for the RFS of cervical cancer patients (Fig. 1). The gene discussed is LGR6; the disease is cervical carcinoma.